全文获取类型
收费全文 | 1973篇 |
免费 | 165篇 |
专业分类
耳鼻咽喉 | 9篇 |
儿科学 | 77篇 |
妇产科学 | 49篇 |
基础医学 | 195篇 |
口腔科学 | 20篇 |
临床医学 | 191篇 |
内科学 | 459篇 |
皮肤病学 | 10篇 |
神经病学 | 219篇 |
特种医学 | 85篇 |
外科学 | 161篇 |
综合类 | 28篇 |
一般理论 | 117篇 |
预防医学 | 267篇 |
眼科学 | 52篇 |
药学 | 106篇 |
肿瘤学 | 93篇 |
出版年
2023年 | 16篇 |
2022年 | 29篇 |
2021年 | 41篇 |
2020年 | 18篇 |
2019年 | 33篇 |
2018年 | 37篇 |
2017年 | 36篇 |
2016年 | 26篇 |
2015年 | 29篇 |
2014年 | 37篇 |
2013年 | 57篇 |
2012年 | 71篇 |
2011年 | 98篇 |
2010年 | 59篇 |
2009年 | 53篇 |
2008年 | 95篇 |
2007年 | 66篇 |
2006年 | 70篇 |
2005年 | 74篇 |
2004年 | 75篇 |
2003年 | 63篇 |
2002年 | 53篇 |
2001年 | 55篇 |
2000年 | 74篇 |
1999年 | 62篇 |
1998年 | 21篇 |
1997年 | 22篇 |
1996年 | 30篇 |
1995年 | 26篇 |
1994年 | 23篇 |
1993年 | 24篇 |
1992年 | 52篇 |
1991年 | 53篇 |
1990年 | 53篇 |
1989年 | 60篇 |
1988年 | 44篇 |
1987年 | 41篇 |
1986年 | 50篇 |
1985年 | 47篇 |
1984年 | 24篇 |
1983年 | 17篇 |
1982年 | 22篇 |
1981年 | 15篇 |
1980年 | 15篇 |
1979年 | 18篇 |
1977年 | 16篇 |
1976年 | 18篇 |
1975年 | 17篇 |
1967年 | 13篇 |
1966年 | 17篇 |
排序方式: 共有2138条查询结果,搜索用时 31 毫秒
91.
Leigh F. Callahan Wendy J. Smith Theodore Pincus 《Arthritis \u0026amp; Rheumatology》1989,2(4):122-131
Self-report questionnaire scales to assess various constructs of health status were compared in 602 patients with five rheumatic diseases, including 134 rheumatoid arthritis (RA), 216 osteoarthritis (OA), 84 fibromyalgia, 124 systemic lupus erythematosus (SLE), and 43 scleroderma patients. RA patients showed significantly higher degrees of difficulty, dissatisfaction, and pain in performing eight activities of daily living (ADL) compared to patients with the other four diseases (P < 0.01), while SLE patients reported the least difficulty, dissatisfaction and pain. Fibromyalgia patients showed significantly higher scores on a visual analog pain scale than patients with the other four diseases (P < 0.05), followed by OA patients. Fibromyalgia patients reported significantly higher levels of learned helplessness, assessed according to a rheumatology attitudes index (RAI), than patients with all other diseases, and scleroderma patients showed significantly lower RAI scores (P < 0.05). Patients with all five diseases who had not completed high school showed poorer clinical status than patients who had completed high school on all six scales. Significant differences in questionnaire scores were seen for 24 of 30 comparisons (five diseases and six scales) according to formal education level, versus only two according to age, and none according to duration of disease. 相似文献
92.
Sebastian P. Mondaca MD Dazhi Liu PharmD BCOP Jessica R. Flynn Sandy Badson Stefan Hamaway BS Mrinal M. Gounder MD Danny N. Khalil MD PhD Alexander E. Drilon MD Bob T. Li MD MPH Komal L. Jhaveri MD Alison M. Schram MD Katherine E. Kargus RN Mary Kate Kasler DNP MSN Natalie M. Blauvelt Neil H. Segal MD PhD Marinela Capanu PhD Margaret K. Callahan MD PhD David M. Hyman MD Maya Gambarin-Gelwan MD James J. Harding MD 《Cancer》2020,126(22):4967-4974
93.
Scott D. Nash Tigist Astale Andrew W. Nute Danaya Bethea Ambahun Chernet Eshetu Sata Mulat Zerihun Demelash Gessese Gedefaw Ayenew Zebene Ayele Berhanu Melak Mahteme Haile Taye Zeru Zerihun Tadesse Benjamin F. Arnold Elizabeth Kelly Callahan Diana L. Martin 《The American journal of tropical medicine and hygiene》2021,104(1):207
94.
Daniel Callahan 《The Hastings Center report》2018,48(2):18-21
Steven Pinker, a cognitive psychologist and linguist at Harvard and a savant of big ideas, is one of the latest to take on the idea of progress. He does it under the aegis of “enlightenment,” which comes down to a kind of holy trinity of reason, science, and humanism. His new book, Enlightenment Now: The Case for Reason, Science, Humanism, and Progress, is ambitious and cantankerous and heady with hope. On the whole, Pinker makes a good case for the benefits of progress, but with an overdose of feel‐good prose. His greatest failure comes in exaggerating the threats to science and in avoiding some problems altogether. He ignores its complexity, its shadows, its creation of new problems raised by its solutions to old ones. Pinker has a particular animus against bioethics, and he misses what has been, I would argue, at the heart of bioethics from its beginning fifty or so years ago. Bioethics was prompted by a new class of medical dilemmas that require a difficult balancing of harms and benefits. Most of them are still with us, and most of them are the result of the progress of postwar medical research and fast‐changing clinical practices. 相似文献
95.
96.
Noncomparative contraceptive efficacy of cellulose sulfate gel 总被引:1,自引:0,他引:1
Mauck CK Freziers RG Walsh TL Peacock K Schwartz JL Callahan MM 《Obstetrics and gynecology》2008,111(3):739-746
OBJECTIVE: To estimate the 6-month cumulative probability of pregnancy, short-term adverse effects, and acceptability of cellulose sulfate vaginal contraceptive gel. METHODS: Two hundred fertile heterosexual couples were enrolled in this single-center, phase II, 6-month noncomparative study conducted at the California Family Health Council in Los Angeles, California. Couples did not desire pregnancy, were at low risk for sexually transmitted diseases, and agreed to use 3.5 mL of cellulose sulfate gel intravaginally before each coital act as their primary means of contraception. Scheduled follow-up visits took place after one menstrual cycle and at study completion, which occurred after 6 months and six menstrual cycles had elapsed. In addition, participants were instructed to call the site at the onset of each menses to review their diary cards. RESULTS: The cumulative probabilities of pregnancy during 6 months and six cycles of typical use were 13.4% (95% confidence interval [CI] 7.5-19.4%) and 13.9% (95% CI 7.7-20.2%), respectively, and during 6 cycles of correct and consistent ("perfect") use: 3.9% (95% CI 0.0-9.2%). Slightly over one fourth of the women and one man reported experiencing gel-related adverse events, two thirds of which were mild and only possibly related to the gel. Three quarters of women and men reported that they would buy cellulose sulfate gel for contraception. CONCLUSION: Cellulose sulfate vaginal gel yields pregnancy rates comparable to nonoxynol-9 and few adverse events among couples at low risk for sexually transmitted diseases. 相似文献
97.
98.
99.
100.